November 25, 2013

A report in the New York Post that Sears Holdings is looking to sell its Canadian division is false, the retailer said.

November 14, 2013

Dollar General Corporation on Wednesday announced the resignations of Raj Agrawal and Adrian Jones as members of its board of directors, effective Dec. 5, 2013.

November 13, 2013

Facing an increasingly competitive retail landscape, Canadian retailer Loblaw Cos. posted a slight lift in retail sales but, due to incremental margin investment in the back half of the year, lowered its earnings growth expectations for 2013. However, company executives are optimistic as the company remains focused on investing in what it refers to as the “customer proposition” and looks forward to its acquisition of Shoppers Drug Mart.

November 11, 2013

Shire will pay $4.2 billion to buy a drug maker specializing in treatments for rare diseases.

November 8, 2013

Merging two classic men’s grooming brands, Procter & Gamble unveiled earlier this year Head & Shoulders with Old Spice.

November 8, 2013

Salix Pharmaceuticals will buy Santarus for $2.6 billion, the drug makers said.

November 6, 2013

Industry veteran Albert Sebok, who held a distinguished career as a pharmacist and healthcare advocate, passed away on Nov. 3.

November 6, 2013

A pharmacist in Canada has won a prestigious award from Pfizer Consumer Healthcare, according to published reports.

November 5, 2013

Endo Health Solutions will acquire Canadian drug maker Paladin Labs for $1.6 billion, mostly in shares of stock, Endo said Tuesday.

November 4, 2013

Crossmark on Monday announced the acquisition of the assets of PromoWorks, an insights-driven shopper marketing solutions firm.

November 4, 2013

Dollar General on Monday announced a number of senior management changes.

October 30, 2013

A division of inVentiv Health has acquired Catalina Marketing's medication adherence services subsidiary, inVentiv said Thursday.

October 30, 2013

The Paws Pet Co. is buying an Irvine, Calif.-based compounding pharmacy as it seeks to transition from a pet company into a pharmaceutical company, Paws said.

October 29, 2013

Actavis had sales of $2.01 billion in third quarter 2013, a 57% increase over the same period last year, the drug maker said Tuesday.

October 23, 2013

Drug maker Depomed has sold its interests in royalty and milestone payments for several Type 2 diabetes drugs to PDL BioPharma, Depomed said.

October 18, 2013

Francisco Partners, a technology-focused private equity firm, earlier this week signed a definitive agreement to acquire McKesson Automation, a unit of McKesson Corp. that offers integrated pharmacy automation solutions for hospitals and health systems.

October 15, 2013

AstraZeneca has acquired a British developer of biotech drugs for treating cancer, AstraZeneca said Tuesday.

October 10, 2013

Anti-aging products, once the darling of the facial skin care category, have experienced a slowdown in growth since the recession — due, in part, to an influx of new products and likely some cannibalization from such multitasking products as BB creams. Meanwhile, skin care staples like facial moisturizers and cleansers have moved into the lead. And while the overall facial skin care category is projected to see little growth in 2013, industry sources suggest that a turnaround is on the horizon.

October 10, 2013

A subsidiary of Johnson & Johnson has acquired rights to an experimental drug for hepatitis C from GlaxoSmithKline.

October 4, 2013

Giant Food Stores turned 90 Friday, the Ahold USA-owned supermarket chain said.

October 3, 2013

GNC Holdings on Wednesday announced it has acquired A1 Sports Limited (d.b.a. Discount Supplements), a multi-brand sports nutrition e-commerce retailer in the United Kingdom.

September 30, 2013

Amneal Pharmaceuticals has bought rights to four generic drugs from Actavis, Amneal said Monday.

September 10, 2013

Shareholders of Actavis and Warner Chilcott have approved the merger of the two drug makers, the companies said Tuesday.

September 10, 2013

The former CEO of Bausch + Lomb has been appointed president and CEO of Forest Labs, the drug maker said Tuesday.